kw.\*:("CA")
Results 1 to 25 of 17106
Selection :
THERMODYNAMIC DATA FOR CALCIUM-BASED ALLOYS FROM A NEW GALVANIC METHOD = DONNEES THERMODYNAMIQUES POUR LES ALLIAGES A BASE DE CALCIUM A PARTIR D'UNE NOUVELLE METHODE GALVANIQUENOTIN M; HERTZ J.1982; CALPHAD; ISSN 0364-5916; USA; DA. 1982; VOL. 6; NO 1; PP. 49-56; BIBL. 15 REF.Article
Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?AYHAN, Ali; GUVEN, Suleyman; GUVEN, Emine Seda Guvendag et al.Acta obstetricia et gynecologica Scandinavica. 2007, Vol 86, Num 4, pp 484-490, issn 0001-6349, 7 p.Article
Maternal serum and umbilical cord tumor marker levels at term pregnancyKIRAN, Gurkan; KIRAN, Hakan; GULER, Fatma Inanc et al.Acta obstetricia et gynecologica Scandinavica. 2005, Vol 84, Num 1, pp 85-89, issn 0001-6349, 5 p.Article
The effect of maternal age, parity, and fetal sex on the amniotic fluid and maternal serum levels of CA 125, CA 19.9, CA 15.3, and CEATAYYAR, M; TUTUS, A.International journal of fertility and women's medicine. 1999, Vol 44, Num 5, pp 256-259, issn 1534-892XArticle
Elevated CA 19-9 levels in mature cystic teratoma of the ovaryMIN SUN KYUNG; JOONG SUB CHOI; SEUNG HWA HONG et al.The International journal of biological markers. 2009, Vol 24, Num 1, pp 52-56, issn 0393-6155, 5 p.Article
Retrorectal cystic hamartoma as benign cause of CA 19-9 elevationGARCIA-DONAS, Jesus; RODRIGUEZ, Nuria; JARA, Carlos et al.Journal of clinical oncology. 2007, Vol 25, Num 25, pp 4012-4014, issn 0732-183X, 3 p.Article
TITRATION OF THE NUCLEOTIDE BINDING SITES OF SARCOPLASMIC RETICULUM CA2+-ATPASE WITH 2',3'-O-(2,4,6-TRINITROPHENYL) ADENOSINE 5'-TRIPHOSPHATE AND 5'-DIPHOSPHATEDUPONT Y; CHAPRON Y; POUGEOIS R et al.1982; BIOCHEM. BIOPHYS. RES. COMMUN.; ISSN 0006-291X; USA; DA. 1982; VOL. 106; NO 4; PP. 1272-1279; BIBL. 21 REF.Article
Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosisHARADA, Tatsuya; KUBOTA, Toshiro; ASO, Takeshi et al.Fertility and sterility. 2002, Vol 78, Num 4, pp 733-739, issn 0015-0282, 7 p.Article
CATALYTIC AND REGULATORY ATP-BINDING SITES OF THE RED CELL CA2+ PUMP STUDIED BY IRREVERSIBLE MODIFICATION WITH FLUORESCEIN ISOTHIOCYANATEMUALLEM S; KARLISH SJD.1983; JOURNAL OF BIOLOGICAL CHEMISTRY; ISSN 0021-9258; USA; DA. 1983; VOL. 258; NO 1; PP. 169-175; BIBL. 44 REF.Article
Menstrual cycle dependent variability for serum tumor markers CEA, AFP, CA 19-9, CA 125 and CA 15-3 in healthy womenERBAGCI, A. B; YILMAZ, N; KUTLAR, I et al.Disease markers. 1999, Vol 15, Num 4, pp 259-267, issn 0278-0240Article
Évaluation analytique et clinique des marqueurs tumoraux Vitros ECi = Tumor marker multicenter analytical and clinical evaluation with Vitros EciECHE, N; RIEDINGER, J.-M; BASUYAU, J.-P et al.Immuno analyse & biologie spécialisée. 2001, Vol 16, Num 5, pp 324-337, issn 0923-2532Article
Dosage des marqueurs tumoraux ACE, CA 15.3, CA 125 et CA 19.9 dans les liquides d'épanchement et le LCR par immunoanalyse en phase homogène. Corrélation avec les résultats cytologiques et les concentrations sériques = Assay of tumor markers (CEA, CA 15-3, CA 125 and CA 19-9) in malignant effusions and cerebrospinal fluid by aid of Kryptor: correlation with cytologic results and blood concentrationsGUEPRATTE, S; PALLUD, C; PICHON, M. F et al.Immuno analyse & biologie spécialisée. 2002, Vol 17, Num 1, pp 18-25, issn 0923-2532Article
Pièges et problèmes analytiques dans le dosage des marqueurs tumoraux circulants = Pitfalls and analytical problems in the measuring of tumour markersBUGUGNANI, M. J; NERBONNE-BLETON, F.Spectra biologie. 2000, Vol 19, Num 112, pp 31-35, issn 0295-1967Conference Paper
Marqueurs tumoraux en cancérologie gynécologique = Tumorous markers in gynecological neoplasmsMIGNOT, L.Contraception, fertilité, sexualité (1991). 1999, Vol 27, Num 10, pp 670-674, issn 1157-8181Article
Epidermoid cyst of the spleen with elevated levels of CA125 and carcino-embryonic antigenARDA, Irfan Serdar; TÜZÜN, Meric; HICSÖNMEZ, Akgun et al.European journal of pediatrics. 2005, Vol 164, Num 2, issn 0340-6199, p. 108Article
Analytical performance and clinical concordance of the cancer biomarkers CA 15-3, CA 19-9, CA 125 II, Carcinoembryonic Antigen, and Alpha-Fetoprotein on the Dimension Vista® SystemCHRISTENSON, Robert H; CERVELLI, Denise R; STERNER, Jamie et al.Clinical biochemistry. 2011, Vol 44, Num 13, pp 1128-1136, issn 0009-9120, 9 p.Article
Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disordersMOORE, Richard G; CRAIG MILLER, Michael; STEINHOFF, Margaret M et al.American journal of obstetrics and gynecology. 2012, Vol 206, Num 4, pp 351-353, issn 0002-9378, 3 p.Article
Calcium aluminate cementsHOLTERHOFF, A. G.American Ceramic Society bulletin. 1994, Vol 73, Num 6, pp 90-91, issn 0002-7812Article
Clinical evaluation of the simultaneous determination of CA 15-3, CA 125 and sHER2 in breast cancerBASKIC, Dejan; RISTIC, Petar; MATIC, Snezana et al.Biomarkers (London. Print). 2007, Vol 12, Num 6, pp 657-667, issn 1354-750X, 11 p.Article
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcomeYERUSHALMI, R; TYLDESLEY, S; KENNECKE, H et al.Annals of oncology. 2012, Vol 23, Num 2, pp 338-345, issn 0923-7534, 8 p.Article
Fluctuations in CA 125 and CA 15-3 serum concentrations during spontaneous ovulatory cyclesBON, G. G; KENEMANS, P; DEKKER, J. J et al.Human reproduction (Oxford. Print). 1999, Vol 14, Num 2, pp 566-570, issn 0268-1161Article
Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinomaGRANKVIST, K; LJUNGBERG, B; RASMUSON, T et al.International journal of cancer. 1997, Vol 74, Num 2, pp 233-236, issn 0020-7136Article
OBSERVATIONS OF TWO OBSCURED GALAXIES IN CYGNUS.VAN DEN BERGH S; HERBST W.1977; ASTR. AND ASTROPHYS.; GERM.; DA. 1977; VOL. 54; NO 3; PP. 723; BIBL. 1 REF.Article
Benign epithelial cyst of the spleen with a high production of carbohydrate antigen 19-9ISHIBASHI, R; SAKAI, T; YAMASHITA, Y et al.International surgery. 1999, Vol 84, Num 2, pp 151-154, issn 0020-8868Article
Elevated serum CA 125 levels in mitral stenotic patients with Heart failureDUMAN, Can; ERCAN, Ertugrul; TENGIZ, Istemihan et al.Cardiology. 2003, Vol 100, Num 1, pp 7-10, issn 0008-6312, 4 p.Article